Health Problems

Trial participation among factors influencing risk of relapse in AYA leukemia patients

Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) were significantly more likely to relapse than pediatric ALL patients, and factors including lower clinical trial enrollment and shorter duration of therapy were associated with relapse. The study is published in the Cancer Epidemiology, Biomarkers & Prevention, by Julie A. Wolfson, MD, MSHS, assistant […]

Health Problems

Results from the ULTIMATE trial reported

September 24, 2018—The first study designed to determine the benefits of intravascular ultrasound (IVUS) guidance over angiography guidance during drug-eluting stent (DES) implantation in all-comer patients found that IVUS improved clinical outcomes by lowering the rate of target vessel failure at one year. Findings from the ULTIMATE trial were reported today at the 30th annual […]

Health News

First HIV immunotherapy drug proves safe in phase 1 trial

First ever HIV immunotherapy drug proves safe in phase 1 trial – paving the way to a cure Scientists at UNC and Children’s National Health System have proved the safety of immunotherapy in HIV patients They are receiving $4m a year for 5 years from GlaxoSmithKline in a bid to arrive at the first HIV cure […]